TY - JOUR
T1 - Synthesis of some 3,4-disubstituted-6,7-dihydro-imidazo[2,1-b][1,3]thiazole and 3,4-disubstituted-7,8-dihydro-6H-imidazo[2,1-b][1,3]thiazine derivatives and evaluation of their cytotoxicities against F2408 and 5RP7 cells
AU - Meriç, Asiye
AU - Incesu, Zerrin
AU - Hatipoǧlu, Ibrahim
PY - 2008/4
Y1 - 2008/4
N2 - This article describes the synthesis of 3,4-disubstituted-6,7-dihydro- imidazo[2,1-b][1,3]thiazoles and 3,4-disubstituted-7,8-dihydro-6H-imidazo[2,1-b] [1,3]thiazines, having substituted or nonsubstituted phenyl rings at the 5,6 and 2,3 positions, respectively, their cytotoxic effects through noncancer (F2408) and cancer (5RP7) cells, and their detailed 1H- and 13C-nuclear magnetic resonance (NMR) spectral characterization. The title compounds were obtained by the cyclization of 4,5-diaryl-imidazole-2- thione and dihaloalkane (i.e., 1,2-dihaloethane or 1,3-dihalopropane), in the presence of potassium carbonate (K2CO3) in N,N-dimethyl formamide (DMF). 4,5-Diaryl-imidazole-2-thione was prepared by condensation of α-hydroxyketones (acyloins), which were obtained by treating aldehydes with cyanide, with thioureas in AcOH. The structure of imidazo[2,1-b][1,3] thiazole and imidazo[2,1-b][1,3]thiazine derivatives was confirmed by infrared (IR), 1H-NMR, and 13C-NMR. The cytotoxicities of the synthesized compounds on both of noncancer (F2408) and cancer (5RP7) cells were measured by 3-(4,5-dimethyl-thiazollyl-2)-2,5-diphenyltetrazolium (MTT) assay. In the presence of only lower doses of compounds 9 and 11, bearing methyl or methoxy substituents on the phenyl ring of imidazo[2,1-b][1,3]thiazole scaffold, the cytotoxic effect was higher on 5RP7 cells than control cells after 24 h.
AB - This article describes the synthesis of 3,4-disubstituted-6,7-dihydro- imidazo[2,1-b][1,3]thiazoles and 3,4-disubstituted-7,8-dihydro-6H-imidazo[2,1-b] [1,3]thiazines, having substituted or nonsubstituted phenyl rings at the 5,6 and 2,3 positions, respectively, their cytotoxic effects through noncancer (F2408) and cancer (5RP7) cells, and their detailed 1H- and 13C-nuclear magnetic resonance (NMR) spectral characterization. The title compounds were obtained by the cyclization of 4,5-diaryl-imidazole-2- thione and dihaloalkane (i.e., 1,2-dihaloethane or 1,3-dihalopropane), in the presence of potassium carbonate (K2CO3) in N,N-dimethyl formamide (DMF). 4,5-Diaryl-imidazole-2-thione was prepared by condensation of α-hydroxyketones (acyloins), which were obtained by treating aldehydes with cyanide, with thioureas in AcOH. The structure of imidazo[2,1-b][1,3] thiazole and imidazo[2,1-b][1,3]thiazine derivatives was confirmed by infrared (IR), 1H-NMR, and 13C-NMR. The cytotoxicities of the synthesized compounds on both of noncancer (F2408) and cancer (5RP7) cells were measured by 3-(4,5-dimethyl-thiazollyl-2)-2,5-diphenyltetrazolium (MTT) assay. In the presence of only lower doses of compounds 9 and 11, bearing methyl or methoxy substituents on the phenyl ring of imidazo[2,1-b][1,3]thiazole scaffold, the cytotoxic effect was higher on 5RP7 cells than control cells after 24 h.
KW - 6,7-Dihydro-imidazo[2,1-b][1, 3]thiazoles
KW - 7,8-Dihydro-6H-imidazo[2,1-b][1,3]thiazines
KW - Bridgehead nitrogen
KW - Fused azole heterocycles
UR - http://www.scopus.com/inward/record.url?scp=50949094337&partnerID=8YFLogxK
U2 - 10.1007/s00044-008-9090-7
DO - 10.1007/s00044-008-9090-7
M3 - Article
AN - SCOPUS:50949094337
SN - 1054-2523
VL - 17
SP - 30
EP - 41
JO - Medicinal Chemistry Research
JF - Medicinal Chemistry Research
IS - 1
ER -